A Case of Primary Central Nervous System Lymphoma that Developed during the Treatment of Castration-Resistant Prostate Cancer

DOI HANDLE Web Site Open Access

Bibliographic Information

Other Title
  • 去勢抵抗性前立腺癌治療中に発症した中枢神経原発悪性リンパ腫の1例
  • キョセイ テイコウセイ ゼンリツセンガン チリョウ チュウ ニ ハッショウ シタ チュウスウ シンケイ ゲンパツ アクセイ リンパシュ ノ 1レイ

Search this article

Description

A 64-year-old man was diagnosed with metastatic prostate cancer (cT3bN0M1b) and treated with combined androgen blockade. After two years and three months, he developed castration-resistant prostate cancer. Multiple lung metastases appeared after the administration of five courses of docetaxel and four courses of cabazitaxel therapy. Pulmonary metastases disappeared following rechallenge with docetaxel. Enzalutamide administration was initiated because docetaxel had to be discontinued due to adverse events. Although enzalutamide lowered the prostate specific antigen value, the patient staggered while walking and developed homonymous hemianopsia. Magnetic resonance imaging revealed a brain tumor. Although the brain tumor was considered to have metastasized from the prostate cancer, it was diagnosed as a primary central nervous system lymphoma using open-ended tumor biopsy. The brain tumor was eliminated with whole-brain irradiation. Thereafter, he has been treated with enzalutamide for 3 years without clinical progression of either disease.

Journal

  • 泌尿器科紀要

    泌尿器科紀要 66 (2), 49-52, 2020-02-29

    泌尿器科紀要刊行会

Keywords

Details 詳細情報について

Report a problem

Back to top